Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.00
Bid: 95.00
Ask: 99.00
Change: 2.00 (2.11%)
Spread: 4.00 (4.211%)
Open: 95.00
High: 97.00
Low: 95.20
Prev. Close: 95.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

19 Sep 2023 07:00

RNS Number : 8393M
Concurrent Technologies PLC
19 September 2023
 

19 September 2023

Concurrent Technologies PLC

(the "Company")

Interim Results for the six months ended 30 June 2023

 

Concurrent Technologies PLC (AIM: CNC), a world leading specialist in high-end embedded computer products for critical applications, announces its interim results for the six months to 30 June 2023 ("H1 2023").

 

Financial Performance

Strengthened order intake has translated into record H1 2023 revenue at £12.1M (representing a 63% increase on H1 2022, and a 22% increase on H1 2020, which was the best revenue year to date). Demand for the Company's products remains strong with a H1 order intake of £14.5M (H1 2022: £14.2M) and record backlog of £29M (31 December 2022: £26.7M). Despite ongoing challenges with component supply, it is reducing in both difficulty of supply and lead times, beginning to unlock what had otherwise been a major constraint to revenue for the previous 2 years, and will ease further throughout the remainder of this year.

· Revenue of £12.1M (H1 2022: £7.4M) - remained constrained by components, however, represents a record half year, with an increase of 63% on prior year.

· Gross profit of £6.0M (H1 2022: £3.7M); an increase of 62% on prior year.

· Gross margin of 49.7% (H1 2022: 50.4%) - reduced as the result of price increases of some components due to high demand and limited supply, and increased manpower costs.

· Operating profit of £1.0M (H1 2022: £0.0M) - predominantly driven by increase revenue, and hence gross profit (+£2.3M); net costs increased by c£1.3M, in line with investment strategy (Enabling Functions e.g. People, Commercial, Procurement; Operations e.g. talent, 2 shifts; Engineering talent; Facilities e.g. Theale office; Leadership team).

· Profit before tax of £1.0M (H1 2022: £0.0M).

· EPS of 1.54 pence (H1 2022: 0.75 pence); increase of 105% on prior year.

· Cash Balance (including cash deposits) as at 30 June 2023 of £3M (31 Dec 2022: £4.5M).

Increased cash from Operations of £0.5M (due to a stronger H1), including increased inventory of £1M.

Decrease of £2M from investment activity, predominantly driven by R&D (£1.7M).

 

Operational Summary

· Strong order intake of £14.5M as at 30 June 2023, with significant backlog of £29M compared to £20.3M backlog as at 30 June 2022, up 42%.

· Revenue defined by components availability in H1.

· Defence remains the largest market sector at 73% revenue.

· Global customer base is solid with exports generating +90% of revenue.

· Investment in R&D costs (talent, improved process & analysis, materials) have continued (+£0.4M), in line with stated strategy to improve the cadence and time to market of products that offer the very latest technology.

· Launched new product Hermes, the latest processer plug-in card.

· Key Partnership agreement announced with Alpha Data to act as a reseller of their FPGA (Field Programmable Gate Array) based plug in card.

· New distributor agreement with SoC-e to enable the company to offer the portfolio of Relyum Advanced Networking Solutions.

· Component shortages have remained challenging, limiting the company's ability to ship product. This is expected to ease in H2 2023.

· Major new systems order with FTSE 250 customer for £1.25M.

 

Miles Adcock, CEO of Concurrent Technologies, commented: "We are delivering on our commitment to transition our core Single Board Computer business into growth. We maintained focus and investment throughout a difficult period of component constraints; and are now seeing the customer demand for our new products reflected as increased revenues. In parallel we have been underpinning capability in relation to a wider systems offering, utilising our own products, but also partners' products for use in higher value products and services. This progress on multiple fronts creates the right conditions for our recently announced equity raise and associated acquisition of Phillips Aerospace to accelerate our Systems strategy. Together these developments provide us with confidence for the future."

 

CHAIRMAN'S STATEMENT

The first half of 2023 has seen a significant recovery in the trading performance of the Company, with record revenues as the component shortages ease, although key shortages are still an issue impacting our ability to convert backlog into revenue. Order intake remains strong and our improved time to market with new innovative products will further grow and broaden our customer base.

The acquisition of Phillips Aerospace in September 2023 is an important step in growing our Systems business, transforming the Company beyond our historic Single Board focus, with the potential for a step change in the available market opportunity for the Company.

Although an interim dividend is not being declared, we are confident we will continue the recovery in the second half of 2023 which will allow us to consider the re-introduction of a full year dividend.

 

CHIEF EXECUTIVE'S REVIEW

Financial Summary

The performance of the Company has remained challenged through limitations of component supply in H1 2023, resulting in a restricted, although record, revenue of £12.1M (H1 2022 £7.4M), a significant increase of 63% on prior year. The company continues to have strong backlog (contracted work) at £29M at H1 2023 (H1 2022: £20.3M), and the Company expects H2 2023 component supply to be improved over that of H1 2023, following a critical delivery in July 2023.

Gross margin is 49.7% (H1 2022; 50.4) which is driven primarily by cost of components. The company has seen a rise in prices during the period of shortage and high demand.

The Company has delivered an unaudited profit before tax of £1M (H1 2022; £0.0M). This is a £1M increase on 2022, represented by the increase revenue (+£4.7M on H1 2022) and corresponding gross profit (+£2.3M), however net operating expenses were up on prior year, in line with the investment strategy at £5.0M (H1 2022: £3.7M). This is driven predominantly by additional investment in talent in R&D (+£0.4M), enabling functions and the Leadership team (+£0.7M). The Company also benefitted from a £0.4M foreign exchange rate gain in H1 2022, not repeated in H1 2023.

The balance sheet remains strong with no debt and £3M of cash balances (including cash deposits) as at 30 June 2023 (31 December 2022: £4.5M). Component supply issues have continued to dominate H1 2023, and this has meant a further investment in inventory and a restricted level of revenue, resulting in a lower cash profile. The Company expects to see this start to reverse in H2 2023, as component supply eases. Inventory holdings have increased to £11M by the end of H1 2023 (H1 2022: £9.5M), an increase of a further £1M since 31 December 2022. The Company is confident in the quality of the inventory held and that it will see a reduction in the levels during H2 2023. Trade receivables were relatively high at the end of H1 2023 at £5.3M (H1 2022: £3.5M) due to the timing and level of revenue, which was £4.7M higher than H1 2022.

With a record order intake in 2022, and further order intake in H1 2023 of £14.5M, and therefore a significant contracted backlog of £29M, plus easing component supply issues, the Company is confident in its H1 2023 outlook.

Post Interim Close Events

On 6 September 2023 the Company completed the acquisition of Phillips Aerospace for US$3.4m through a combination of US$1.9m cash and the issue of equity of $1.5m to the owners of Phillips Aerospace. Simultaneously the Company raised £6.8m through the issue of fresh equity approved by shareholders at a General Meeting held on 4 September 2023. These events broaden our product offering and strengthen the balance sheet to drive further growth.

Current Trading & Outlook

With a record H1 backlog of £29M and the component supply chain issues easing, the Company is in a good position to begin to revert to strong trading (largely no longer defined by component availability). The Company continues on its growth journey, with the underpinning of its systems strategy through the acquisition of Phillips Aerospace (post H1), and the continued drive in maximising capacity (additional shifts, maximising space, use of third-party manufacturer) allowing for further growth into 2024 and beyond. The product portfolio continues to strengthen with continued investment in R&D and sales, enabling a strong pipeline of opportunities, and conversion of these, to underpin future revenue growth.

Together, these strategic developments continue to provide confidence for the future performance of the Company.

 

 

 

 

Enquiries:

 

Concurrent Technologies Plc Miles Adcock, CEO

Kim Garrod, CFO

 

+44 (0)1206 752626

Newgate (Financial PR) Bob Huxford

Alice Cho

Matthew Elliott

concurrent@secnewgate.co.uk

+44 (0)20 3757 6880

Cavendish Securities plc (NOMAD) Neil McDonald

Peter Lynch

+44 (0)131 220 9771

+44 (0)131 220 9772

 

 

 

 

 

 

Condensed Consolidated Statement of Comprehensive Income

Unaudited interim results to 30th June 2023

Six months

 

Six months

 

Year

 

ended

 

ended

 

ended

 

Note

30/06/23

 

30/06/22

 

31/12/22

 

CONTINUING OPERATIONS

 

£

 

£

 

£

 

Revenue

 

12,139,625

7,421,285

18,274,771

Cost of sales

(6,100,879)

(3,680,258)

(9,397,449)

Gross profit

 

6,038,746

3,741,027

8,877,322

Net operating expenses

(5,028,784)

(3,688,676)

(8,390,682)

Group operating profit

 

1,009,962

52,351

486,640

Interest Costs

(52,871)

(26,930)

(104,505)

Finance income

16,405

6,992

546

Other Income

-

-

-

Profit before tax

 

973,496

32,413

382,681

Tax

154,441

518,890

604,344

Profit for the period

 

1,127,937

551,303

987,025

Other Comprehensive Income

 

Exchange differences on translating foreign operations

(41,338)

100,789

69,463

Tax relating to components of other comprehensive income

-

-

-

Other Comprehensive Income for the period, net of tax

(41,338)

100,789

69,463

Total Comprehensive Income for the period

 

1,086,599

652,092

1,056,488

Profit for the period attributable to:

 

Equity holders of the parent

1,127,937

551,303

987,025

Total Comprehensive Income attributable to:

 

Equity holders of the parent

1,086,599

652,092

1,056,488

Earnings per share

 

Basic earnings per share

4

1.54p

0.75p

 1.35p

Diluted earnings per share

4

1.54p

0.75p

 1.35p

Adjusted earnings per share

1.54p

0.75p

 1.35p

 

 

 

 

 

 

 

Condensed Consolidated Balance Sheet

Unaudited interim results to 30th June 2023

As at

 

As at

 

As at

 

30/06/23

 

30/06/22

 

31/12/22

ASSETS

 

£

 

£

 

£

Non-current assets

 

Property, plant and equipment

2,528,605

2,445,996

2,685,107

Intangible assets

9,843,724

9,058,713

8,807,290

Deferred tax assets

321,577

7,243

350,753

Other Financial Assets

-

-

-

12,693,906

11,511,952

11,843,150

Current assets

 

Inventories

11,048,329

9,460,432

10,090,437

Trade and other receivables

5,337,017

3,460,344

5,439,912

Current tax assets

1,126,010

597,086

762,545

Other Financial Assets

-

-

-

Cash and cash equivalents

2,976,823

9,265,663

4,512,720

20,488,179

22,783,525

20,805,614

Total assets

 

33,182,086

34,295,477

32,648,764

LIABILITIES

 

Non-current liabilities

 

Deferred tax liabilities

2,311,767

2,176,884

2,126,588

Trade and other payables

1,118,819

505,767

1,257,820

Long term provisions

309,735

18,256

304,336

3,740,321

2,700,907

3,688,744

Current liabilities

 

Trade and other payables

5,165,320

7,119,058

5,765,262

Short term provisions

18,256

18,256

18,256

Current tax liabilities

51,864

15,779

-

5,235,440

7,153,093

5,783,518

Total liabilities

 

8,975,761

9,854,000

9,472,262

Net assets

 

24,206,325

24,441,477

23,176,502

EQUITY

 

Capital and reserves

 

Share capital

739,000

739,000

739,000

Share premium account

3,699,105

3,699,105

3,699,105

Capital redemption reserve

256,976

256,976

256,976

Cumulative translation reserve

(69,274)

3,390

(27,936)

Profit and loss account

19,580,518

19,743,006

18,509,357

Equity attributable to equity holders of the parent

24,206,325

24,441,477

23,176,502

Total equity

 

24,206,325

24,441,477

23,176,502

 

 

 

Condensed Consolidated Cash Flow Statement

Unaudited interim results to 30th June 2023

 

Six months

 

Six months

 

Year

 

ended

 

ended

 

ended

 

30/06/2023

 

30/06/2022

 

31/12/2022

 

£

 

£

 

£

Cash flows from operating activities

 

Profit before tax for the period

973,496

32,413

382,681

Adjustments for:

Finance income

(16,405)

(6,992)

(546)

Finance costs

52,871

26,930

104,505

Depreciation

447,858

121,589

422,047

Amortisation

650,862

627,395

1,197,972

Impairment loss

-

-

327,526

Loss on disposal of property, plant and equipment (PPE)

-

-

-

Share-based payment

155,603

48,785

219,363

Exchange differences

(44,219)

111,153

82,384

(Increase)/decrease in inventories

(957,892)

(3,034,996)

(3,665,001)

(Increase)/decrease in trade and other receivables

102,895

(471,711)

(2,451,279)

Increase/(decrease) in trade and other payables

(663,334)

2,920,826

2,222,123

Cash generated from operations

701,735

375,392

(1,158,225)

Tax (paid)/received

(155,183)

270,780

267,884

Net cash generated from operating activities

546,552

646,172

(890,341)

Cash flows from investing activities

 

Interest received

16,405

6,992

546

Cash placed on deposit

-

-

-

Purchases of property, plant and equipment (PPE)

(235,971)

(1,124,354)

(1,480,394)

Proceeds from sale of PPE

-

-

-

Purchases of intangible assets

(1,744,508)

(1,993,577)

(3,711,617)

Net cash used in investing activities

(1,964,074)

(3,110,939)

(5,191,465)

Cash flows from financing activities

 

Equity dividends paid

-

-

(1,027,088)

Repayment of leasing liabilities

(70,210)

(64,809)

(94,842)

Interest paid

(52,871)

(26,930)

(104,505)

Cash received from share issue

-

-

-

Purchase of treasury shares

-

-

2,425

Net cash used in financing activities

(123,081)

(91,739)

(1,224,010)

Effects of exchange rate changes on cash and cash equivalents

4,707

(17,589)

(21,222)

Net increase/(decrease) in cash

 

(1,535,896)

(2,574,095)

(7,327,038)

Cash at beginning of period

4,512,720

11,839,758

11,839,758

Cash at the end of the period

2,976,824

9,265,663

4,512,720

 

 

 

 

 

Condensed Consolidated Statement of Changes in Equity

Unaudited interim results to 30th June 2023

Capital

 

Cumulative

 

Profit

 

Share

 

Share

 

redemption

 

translation

 

and loss

 

Total

 

capital

 

premium

 

reserve

 

reserve

 

account

 

Equity

 

£

 

£

 

£

 

£

 

£

 

£

Balance at 1 January 2022

739,000

3,699,105

256,976

(97,399)

18,082,077

22,679,759

Profit for the period

-

-

-

-

551,303

551,303

Exchange differences on translating foreign operations

-

-

-

100,789

-

100,789

Total recognised comprehensive income for the period

-

-

-

100,789

551,303

652,092

Share-based payment

-

-

-

-

48,785

48,785

Deferred tax on share based payment

-

-

-

-

-

Dividends paid

-

-

-

-

-

Sale of treasury shares

-

-

-

-

-

-

Issue of Ordinary shares

-

-

-

-

-

-

Balance at 30 June 2022

739,000

3,699,105

256,976

3,390

18,682,165

23,380,636

Total recognised comprehensive income for the period

-

-

-

-

435,722

435,722

Exchange differences on translating foreign operations

-

-

-

(31,326)

-

(31,326)

Total recognised comprehensive income for the period

-

-

-

(31,326)

435,722

404,396

Share-based payment

-

-

-

-

170,578

170,578

Deferred tax on share based payment

-

-

-

-

245,555

245,555

Dividends paid

-

-

-

-

(1,027,088)

(1,027,088)

Sale of treasury shares

-

-

-

-

2,425

2,425

Balance at 31 December 2022

739,000

3,699,105

256,976

(27,936)

18,509,357

23,176,502

Total recognised comprehensive income for the period

-

-

-

-

1,127,937

1,127,937

Exchange differences on translating foreign operations

-

-

-

(41,338)

-

(41,338)

Total recognised comprehensive income for the period

-

-

-

(41,338)

1,127,937

1,086,599

Share-based payment

-

-

-

-

155,603

155,603

Deferred tax on share based payment

-

-

-

-

(212,379)

(212,379)

Dividends paid

-

-

-

-

-

-

Issue of ordinary shares

-

-

-

-

-

-

Sale of treasury shares

-

-

-

-

-

-

Balance at 30 June 2023

739,000

3,699,105

256,976

(69,274)

19,580,518

24,206,325

 

 

NOTES TO THE INTERIM REPORT

1. General information

The principal activity of the Group is design, manufacture and supply of innovative high-end embedded single board computers and complementary accessories aimed at a wide base of customers within the defence & aerospace, telecommunications, medical and other markets.

Concurrent Technologies PLC ("the Company") is the Group's ultimate parent company. It is incorporated and domiciled in Great Britain. Concurrent Technologies PLC shares are listed on the Alternative Investment Market of the London Stock Exchange.

The Group's condensed consolidated interim financial statements are presented in pounds sterling (£), which is also the functional currency of the parent company.

These condensed consolidated interim financial statements, which are unaudited, have been approved for issue by the Board of Directors on 18 September 2023.

The information relating to the six months ended 30 June 2023 is unaudited and does not constitute statutory accounts within the meaning of section 434 of the Companies Act 2006. The statutory accounts for the year ended 31 December 2022, prepared in accordance with IFRSs (International Financial Reporting Standards) as adopted by the European Union, have been reported on by the Group's auditors and delivered to the Registrar of Companies. The auditor's report was qualified, and this qualification will be addressed in the statutory accounts for 31 December 2023.

2. Summary of significant accounting policies

 

2.1 Basis of preparation

 

These condensed consolidated interim financial statements are for the six months period ended 30 June 2023. They have been prepared in accordance with IAS 34 "Interim Financial Reporting". They do not include all the information required for full annual financial statements and should be read in conjunction with the consolidated financial statements of the Group for the year ended 31 December 2022, which have been been prepared in accordance with adopted IFRSs.

The accounting policies applied, and methods of computation are consistent with those of the annual financial statements for the year end 31 December 2022, as described in those financial statements. The accounting policies have been consistently applied to all the periods presented.

There are no new IFRSs or IFRIC interpretations that are effective for the first time for the financial period beginning on or after 1 January 2023 that would be expected to have a material impact on the results or financial position of the Group.

 

2.2 Going Concern

The Directors are satisfied that the Group has sufficient resources to continue in operation for the foreseeable future, a period of not less than 12 months from the date of this report. Accordingly, the continue to adopt the going concern basis in preparing these condensed financial statements.

2.3 Taxation

 

Current tax expense is recognised in these condensed consolidated interim financial statements based on the estimated effective tax rates for the full year.

 

3. Segmental reporting

The Directors consider that the Group is engaged in a single segment of business, being design, manufacture of high-end embedded computer products and that therefore, the Company has only a single operating segment. The key measure of performance used by the Board to assess the Group's performance is the Group's profit before tax, as calculated under IFRS, and therefore no reconciliation is required between the measure of profit or loss used by the Board and that contained in the condensed consolidated interim financial statements.

4. Earnings per share

Basic earnings per share is calculated by dividing the profit attributable to ordinary equity holders for the period by the weighted average number of ordinary shares outstanding during the period.

Diluted earnings per share is calculated adjusting the weighted average number of ordinary shares outstanding to assume conversion of all contracted dilutive potential ordinary shares. The Company only has one category of dilutive potential ordinary shares, namely share options.

The inputs to earnings per share calculation are shown below:

The inputs to the earnings per share calculation are shown below:

Six months

 

Six months

 

Year

 

ended

 

ended

 

ended

 

30/06/23

 

30/06/22

 

31/12/22

 

£

 

£

 

£

Profit attributable to ordinary equity holders

1,127,937

551,303

987,025

Six months

 

Six months

 

Year

 

ended

 

ended

 

ended

 

30/06/23

 

30/06/22

 

31/12/22

 

 

 

 

Weighted average number of ordinary shares for basic earnings per share

73,363,490

73,673,490

73,363,490

Adjustment for share options

-

Weighted average number of ordinary shares for diluted earnings per share

73,363,490

73,673,490

73,363,490

 

 

5. Shareholder Communication

 

A copy of these condensed interim financial statements is available from the Company's Registered office at:

4 Gilberd Court,

Newcomen Way,

Colchester,

Essex, UK

CO4 9WN

They are also available from the Company's website at www.gocct.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR NKFBBDBKBCCD
Date   Source Headline
24th Apr 20247:00 amRNSUS Contract Win and Notice of Results
9th Apr 20247:00 amRNSNew Product Announcement
5th Feb 20247:00 amRNSBoard Appointment
17th Jan 20247:00 amRNSTrading update
21st Dec 20237:00 amRNSKey VME Contract Win
19th Dec 20231:07 pmRNSHolding(s) in Company
27th Nov 20237:00 amRNSTrading Update
9th Nov 20237:00 amRNSNew Product Announcement
8th Nov 20237:00 amRNSChange of Nominated Adviser
7th Nov 20237:00 amRNSAppointment of New Auditors
2nd Nov 20237:00 amRNSHolding(s) in Company
24th Oct 20237:00 amRNSDirector/PDMR Dealing - Issue of Share Options
28th Sep 20237:00 amRNSNew Product Announcement
19th Sep 20237:00 amRNSInterim Results
6th Sep 20237:00 amRNSAcquisition of Phillips Aerospace
5th Sep 202312:04 pmRNSHolding(s) in Company
5th Sep 20237:00 amRNSNotice of Results
4th Sep 20231:20 pmRNSResult of General Meeting
25th Aug 20237:00 amRNSResult of Retail Offer
24th Aug 20233:07 pmRNSResult of AGM
16th Aug 20237:05 amRNSRetail Offer for up to £0.3 million
16th Aug 20237:00 amRNSProposed Acquisition and Notice of General Meeting
11th Aug 20233:15 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSNew Product Announcement
1st Aug 202310:58 amRNSNew Product Announcement
20th Jul 20237:00 amRNSNotification of Major Holdings
18th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
17th Jul 20237:00 amRNSPost-Close Trading Update
30th Jun 20237:00 amRNSResults for the year ended 31 December 2022
19th Jun 20237:00 amRNSUpdate on Audited Annual Results
12th Jun 20237:00 amRNSSignificant Systems Win
9th Jun 20235:11 pmRNSNotification of Major Holdings
7th Jun 20237:00 amRNSNew Distributor Agreement
5th Jun 20237:00 amRNSNotice of Results
24th Mar 20237:00 amRNSNew Product Announcement
21st Mar 20237:00 amRNSReseller Agreement
4th Jan 20237:00 amRNSPost-Close Trading Update
14th Dec 20227:00 amRNSPartnership Agreement
28th Oct 20227:00 amRNSIssue of Share options and PDMR dealing
5th Oct 20227:00 amRNSConcurrent Technologies Enters the Systems Market
26th Sep 20227:00 amRNSInterim Results
12th Sep 20227:00 amRNSNotice of Interim Results
24th Aug 202210:29 amRNSHolding(s) in Company
24th Aug 202210:27 amRNSHolding(s) in Company
19th Aug 202212:06 pmRNSHolding(s) in Company
13th Jul 20227:00 amRNSSupply Agreement
29th Jun 202212:55 pmRNSResult of AGM
30th May 20227:00 amRNSPosting of Annual Report & Notice of AGM
23rd May 20222:46 pmRNSIssue of Share options and PDMR dealing
12th May 20227:00 amRNSResults for the year ended 31 December 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.